Relationship between levels of Skp2 and P27 in breast carcinomas and possible role of Skp2 as targeted therapy

Steroids

Volumn 70, Issue 11, 2005, Pages 770-774

  Zheng, Wei Qiang ^a   Zheng, Jian Ming ^a   Ma, Rong ^b   Meng, Feng Fang ^c   Ni, Chan Rong ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b Department of Pathology   (China)

^c First People's Hospital   (China)

Author keywords

Breast neoplasm; Estrogen receptor; Immunohistochemistry; p27; Skp2

Indexed keywords

ESTROGEN RECEPTOR; PROTEIN P27; S PHASE KINASE ASSOCIATED PROTEIN 2;

ADULT; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER TISSUE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; PROTEIN EXPRESSION; PROTEIN TARGETING; STATISTICAL ANALYSIS;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL NUCLEUS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MIDDLE AGED; RECEPTORS, ESTROGEN; S-PHASE KINASE-ASSOCIATED PROTEINS; STROMAL CELLS;

EID: 23844500471     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2005.04.012     Document Type: Article

References (21)

1. H. Rochefort, M. Glondu, M.E. Sahla, N. Platet, and M. Garcia How to target estrogen receptor-negative breast cancer Endocr Relat Cancer 10 2003 261 266
2. M. Ellis Overcoming endocrine therapy resistance by signal transduction inhibition Oncologist 9 Suppl. 3 2004 20 26
3. H. Zhang, R. Kobayashi, K. Galaktionov, and D. Beach p19Skp-1 and p45Skp-2 are essential elements of the cyclin A-Cdk2 S phase kinase Cell 82 1995 915 925
4. A.C. Carrano, E. Eytan, A. Hershko, and M. Pagano Skp2 is required for the ubiquitin-mediated degradation of the Cdk-inhibitor p27 Nat Cell Biol 1 1999 193 199
5. H. Toyoshima Hunter T. p27, a novel inhibitor of G1 cyclin-cdk protein kinase activity, is related to p21 Cell 78 1994 67 74
6. J. Tsihlias, L. Kapusta, and J. Slingerland The prognostic significance of altered cyclin-dependent kinase inhibitors in human cancer Annu Rev Med 50 1999 401 423
7. J.S. Ross, D.P. Schenkein, R. Pietrusko, M. Rolfe, G.P. Linette, and J. Stec Targeted therapies for cancer 2004 Am J Clin Pathol 122 2004 598 609
8. C.W. Elston, and I.O. Ellis Pathological prognostic factors in breast cancer. Part 1: the value of histological grade in breast cancer - experience from a large study with long-term follow-up Histopathology 19 1991 403 410
9. J. Slingerland, and M. Pagano Regulation of the cdk inhibitor p27 and its deregulation in cancer J Cell Physiol 183 2000 10 17
10. C.J. Sherr, and J.M. Roberts Inhibitors of mammalian G1 cyclin-dependent kinases Genes Dev 9 1995 1149 1163
11. H. Sutterluty, E. Chatelain, A. Marti, C. Wirbelauer, M. Senften, and U. Muller p45 SKP2 promotes p27 Kip1 degradation and induces S phase in quiescent cells Nat Cell Biol 1 1999 207 214
12. M. Gstaiger, R. Jordan, M. Lim, C. Catzavelos, J. Mestan, and J. Slingerland Sp2 is oncogenic and overexpressed in human cancers Proc Natl Acad Sci USA 98 2001 5043 5048
13. S. Fredersdorf, J. Burns, A.M. Milne, G. Packham, L. Fallis, and C.E. Gillett High level expression of p27 and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27 and degree of malignancy in human breast and colorectal cancers Proc Natl Acad Sci USA 94 1997 6380 6385
14. M. Barbareschi, H. van Tinteren, F.A. Mauri, S. Veronese, H. Peterse, and P. Maisonneuve p27-Expression in breast carcinomas; an immunohistochemical study on 512 patients with long-term follow-up Int J Cancer 89 2000 236 241
15. S. Han, K. Park, H.Y. Kim, M.S. Lee, H.J. Kim, and Y.D. Kim Reduced expression of p27Kip1 protein is associated with poor clinical outcome of breast cancer patients treated with systemic chemotherapy and is linked to cell proliferation and differentiation Breast Cancer Res Treat 55 1999 161 167
16. J.S. Chu, C.S. Huang, and K.J. Chang P27 expression as a prognostic factor of breast cancer in Taiwan Cancer Lett 141 1999 123 130
17. S. Honjo, S. Kase, M. Osaki, T.D. Ardyanto, N. Kaibara, and H. Ito COX-2 correlates with F-box protein. Skp2 expression and prognosis in human gastric carcinoma Int J Oncol 26 2005 353 360
18. R. Palmqvist, R. Stenling, A. Oberg, and G. Landberg Prognostic significance of p27 (Kip1) expression in colorectal cancer: a clinico-pathological characterization J Pathol 188 1999 18 23
19. R. Chiarle, M. Pagano, and G. Inghirami The cyclin dependent kinase inhibitor p27 and its prognostic role in breast cancer Breast Cancer Res 3 2001 91 94
20. J.B. Gibbs Mechanism-based target identification and drug discovery in cancer research Science 287 2000 1969 1973
21. W.Q. Zheng, J. Lu, J.M. Zheng, F.X. Hu, and C.R. Ni Variation of ER status between primary and metastatic breast cancer and relationship to p53 expression Steroids 66 2001 905 910